Perfluorocarbon-based oxygen-shuttling nanocarriers and carbonic anhydrase IX-targeting nanoparticles reversed drug resistance in hypoxic renal carcinoma models (116, 266, 267). The gene discussed is CA9; the disease is renal carcinoma.